Clinical use of evidence-based medicine - Clinical questions

Wisconsin Medical Journal

Volumn 106, Issue 1, 2007, Pages 7-8

  Hsu, Jennifer ^a   Pack, Quinn ^a   Feldstein, David A ^a,b  

^a University of Wisconsin Health   (United States)

^b MC 9499 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PLACEBO;

ACUTE CORONARY SYNDROME; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DOSE RESPONSE; DRUG EFFECT; GASTROINTESTINAL HEMORRHAGE; HEART DEATH; HEART INFARCTION; HUMAN; NOTE; RECURRENT DISEASE; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; STROKE; SUBSTERNAL PAIN; TREATMENT OUTCOME;

ASPIRIN; CORONARY DISEASE; EVIDENCE-BASED MEDICINE; GASTROINTESTINAL HEMORRHAGE; HUMANS; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS;

EID: 33847102743     PISSN: 10981861     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (1)

1. Peters RJ, Mehta SR, Fox KA, et al. Effect of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Circulation. 2003;108(14):1682-1687. 41